Published in Mol Cell Biochem on May 01, 2005
Pathway-based analysis for genome-wide association studies using supervised principal components. Genet Epidemiol (2010) 1.25
T-cadherin is essential for adiponectin-mediated revascularization. J Biol Chem (2013) 1.05
The mouse QTL map helps interpret human genome-wide association studies for HDL cholesterol. J Lipid Res (2011) 0.98
Genetic loci for blood lipid levels identified by linkage and association analyses in Caribbean Hispanics. J Lipid Res (2011) 0.92
Specific electrochemical iodination of horse heart myoglobin at tyrosine 103 as determined by Fourier transform ion cyclotron resonance mass spectrometry. Arch Biochem Biophys (2008) 0.86
Clinicopathological significance and potential drug target of T-cadherin in NSCLC. Drug Des Devel Ther (2014) 0.85
Functional properties of rare missense variants of human CDH13 found in adult attention deficit/hyperactivity disorder (ADHD) patients. PLoS One (2013) 0.82
PDZ domain-containing 1 (PDZK1) protein regulates phospholipase C-β3 (PLC-β3)-specific activation of somatostatin by forming a ternary complex with PLC-β3 and somatostatin receptors. J Biol Chem (2012) 0.81
Prognostic significance of CDH13 hypermethylation and mRNA in NSCLC. Onco Targets Ther (2014) 0.78
A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem (1985) 90.20
A receptor-mediated pathway for cholesterol homeostasis. Science (1986) 19.28
Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol (2003) 18.97
Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu Rev Cell Biol (1985) 11.53
Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol (1983) 10.95
Sticky business: orchestrating cellular signals at adherens junctions. Cell (2003) 4.91
The cadherin superfamily: diversity in form and function. J Cell Sci (2001) 2.63
Effects of cyclopiazonic acid, a novel Ca(2+)-ATPase inhibitor, on contractile responses in skinned ileal smooth muscle. Br J Pharmacol (1992) 1.71
Cyclopiazonic acid depletes intracellular Ca2+ stores and activates an influx pathway for divalent cations in HL-60 cells. J Biol Chem (1992) 1.71
T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region. Neuron (1991) 1.65
Structure and functions of classical cadherins. Biochemistry (Mosc) (2001) 1.40
Expression of cell adhesion molecule T-cadherin in the human vasculature. Histochem Cell Biol (2001) 1.38
Inhibition of motor axon growth by T-cadherin substrata. Development (1996) 1.25
Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. J Biol Chem (1989) 1.23
Glycosyl phosphatidylinositol--anchored T-cadherin mediates calcium-dependent, homophilic cell adhesion. J Cell Biol (1992) 1.19
Expression of adhesion molecule T-cadherin is increased during neointima formation in experimental restenosis. Histochem Cell Biol (2002) 1.09
T-cadherin and signal-transducing molecules co-localize in caveolin-rich membrane domains of vascular smooth muscle cells. FEBS Lett (1998) 1.03
Cell adhesion molecule T-cadherin regulates vascular cell adhesion, phenotype and motility. Exp Cell Res (2004) 1.02
The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis. J Biol Chem (2000) 1.02
Recent progress in T-cadherin (CDH13, H-cadherin) research. Histol Histopathol (2001) 1.01
Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. Proc Natl Acad Sci U S A (1988) 1.00
T-cadherin expression delineates specific regions of the developing motor axon-hindlimb projection pathway. J Neurosci (1994) 0.97
Activation of human peripheral blood monocytes by lipoproteins. Am J Pathol (1988) 0.96
T-cadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells. Cardiovasc Res (2004) 0.93
Differential targeting of T- and N-cadherin in polarized epithelial cells. J Biol Chem (1996) 0.91
GPI-anchored GFP signals Ca2+ but is homogeneously distributed on the cell surface. Biochem Biophys Res Commun (2002) 0.91
Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells. Proc Natl Acad Sci U S A (1993) 0.91
Increased expression of H/T-cadherin in tumor-penetrating blood vessels. Cancer Res (2000) 0.91
The glycosyl phosphatidylinositol anchor of human T-cadherin binds lipoproteins. Biochem Biophys Res Commun (2000) 0.88
LDL binds to surface-expressed human T-cadherin in transfected HEK293 cells and influences homophilic adhesive interactions. FEBS Lett (1999) 0.86
Polarisation of T-cadherin to the leading edge of migrating vascular cells in vitro: a function in vascular cell motility? Histochem Cell Biol (2003) 0.85
Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique. Biochem J (1996) 0.84
Incorporation of leucocyte GPI-anchored proteins and protein tyrosine kinases into lipid-rich membrane domains of COS-7 cells. Biochem Biophys Res Commun (1998) 0.84
Identification of an atypical lipoprotein-binding protein from human aortic smooth muscle as T-cadherin. FEBS Lett (1998) 0.84
Phosphoinositide and calcium signalling responses in smooth muscle cells: comparison between lipoproteins, Ang II, and PDGF. Biochem Biophys Res Commun (1992) 0.82
Novel cellular activities for low density lipoprotein in vascular smooth muscle cells. Hypertension (1990) 0.82
Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells. Mol Pharmacol (1994) 0.81
Characterization of an atypical lipoprotein-binding protein in human aortic media membranes by ligand blotting. Biochem J (1994) 0.80
Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension. J Hypertens Suppl (1991) 0.80
Rapid activation of human platelets by low concentrations of low-density lipoprotein via phosphatidylinositol cycle. Eur J Biochem (1988) 0.79
Low- and high-density lipoproteins as mitogenic factors for vascular smooth muscle cells: individual, additive and synergistic effects. J Vasc Res (1995) 0.78
Atypical low density lipoprotein binding site that may mediate lipoprotein-induced signal transduction. Mol Pharmacol (1994) 0.77
Identification of 130 kDa cell surface LDL-binding protein from smooth muscle cells as a partially processed T-cadherin precursor. Biochim Biophys Acta (1999) 0.77
LDL- and agonist-induced Ca(2+)-mobilization in platelets of healthy subjects and in patients with familial hyperlipoproteinemia type II. Thromb Res (1991) 0.76
De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry (2011) 4.91
Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J (1997) 2.20
Is pretreatment with Beta-blockers beneficial in patients with acute coronary syndrome? Cardiology (2009) 2.08
Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res (2001) 1.76
Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med (1986) 1.60
Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation. J Mol Biol (1999) 1.55
Simple point-of-care risk stratification in acute coronary syndromes: the AMIS model. Heart (2008) 1.45
Changes of immunoregulatory cells induced by psychological and physical stress: relationship to plasma catecholamines. Clin Exp Immunol (1984) 1.45
Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma (1999) 1.45
Calcium binding to fluorescent calcium indicators: calcium green, calcium orange and calcium crimson. Biochem Biophys Res Commun (1991) 1.44
Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction. Eur Heart J (1996) 1.42
The impact of statin treatment on presentation mode and early outcomes in acute coronary syndromes. Cardiology (2007) 1.40
Comparative effects of haemodialysis and haemofiltration on plasma atrial natriuretic peptide. Nephrol Dial Transplant (1989) 1.39
Expression of cell adhesion molecule T-cadherin in the human vasculature. Histochem Cell Biol (2001) 1.38
Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am J Physiol (1999) 1.36
Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. N Engl J Med (1984) 1.34
Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression. J Clin Invest (1994) 1.33
Trigeminal cardiac reflex: new thinking model about the definition based on a literature review. Medicine (Baltimore) (2015) 1.30
Kinetics of calcium binding to fluo-3 determined by stopped-flow fluorescence. Biochem Biophys Res Commun (1989) 1.30
Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E. Proc Natl Acad Sci U S A (1993) 1.30
A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum Mol Genet (1995) 1.29
Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy. Biochim Biophys Acta (1996) 1.29
Lichens as biomonitors of uranium in the Balkan area. Environ Pollut (2003) 1.22
Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexes. J Biol Chem (1997) 1.17
Different translocation of three distinct PKC isoforms with tumor-promoting phorbol ester in human platelets. Biochem Biophys Res Commun (1991) 1.17
Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin. Curr Biol (2000) 1.13
Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix. Proc Natl Acad Sci U S A (1996) 1.12
Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol Psychiatry (2011) 1.11
Comparison of EPR occupational lifetime external dose assessments for Mayak nuclear workers and film badge dose data. Radiat Environ Biophys (2006) 1.11
The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma. FEBS Lett (1995) 1.09
Calcium and magnesium binding to rat parvalbumin. Eur J Biochem (1994) 1.09
The vasodilator potency of atrial natriuretic peptide in man. Circulation (1987) 1.07
Enhancement of calcium influx in human platelets by CGP 28392, a novel dihydropyridine. Biochem Biophys Res Commun (1984) 1.06
The results and limitations of endoscopic submucosal dissection for colorectal tumors. Acta Chir Iugosl (2008) 1.05
Acute and chronic sympathetic reflex activation and antihypertensive response to nifedipine. J Am Coll Cardiol (1986) 1.05
The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis. J Biol Chem (2000) 1.02
The Third International Intercomparison on EPR Tooth Dosimetry: part 2, final analysis. Radiat Prot Dosimetry (2006) 1.01
S100 alpha, CAPL, and CACY: molecular cloning and expression analysis of three calcium-binding proteins from human heart. Biochemistry (1992) 1.01
A Gs protein couples P2-purinergic stimulation to cardiac Ca channels without cyclic AMP production. J Gen Physiol (1992) 0.99
Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation. Proc Natl Acad Sci U S A (1994) 0.99
Mitochondrial deenergization underlies neuronal calcium overload following a prolonged glutamate challenge. FEBS Lett (1996) 0.98
Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels. FEBS Lett (1986) 0.97
Developmentally imprinted genes as markers for bladder tumor progression. J Urol (1996) 0.95
Renin profiling to select antihypertensive baseline drugs. Renin inhibitors for high-renin and calcium entry blockers for low-renin patients. Am J Med (1984) 0.94
Factors influencing the hypotensive effects of calcium antagonists. Hypertension (1983) 0.92
RFP2, c13ORF1, and FAM10A4 are the most likely tumor suppressor gene candidates for B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet (2003) 0.92
Characterization of the human and mouse cDNAs coding for S100A13, a new member of the S100 protein family. Biochem Biophys Res Commun (1996) 0.91
Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy. Am J Cardiol (1987) 0.91
Topologically protected quantum bits using Josephson junction arrays. Nature (2002) 0.90
Myocardial tissue characterization in heart failure by real-time integrated backscatter. Eur J Ultrasound (1999) 0.90
Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.90
Dominant role of mitochondria in protection against a delayed neuronal Ca2+ overload induced by endogenous excitatory amino acids following a glutamate pulse. FEBS Lett (1996) 0.89
Urokinase plasminogen activator induces smooth muscle cell migration: key role of growth factor-like domain. FEBS Lett (1997) 0.89
S100A1 deficiency results in prolonged ventricular repolarization in response to sympathetic activation. Gen Physiol Biophys (2008) 0.89
The glycosyl phosphatidylinositol anchor of human T-cadherin binds lipoproteins. Biochem Biophys Res Commun (2000) 0.88
Platelet membrane calmodulin-stimulated calcium-adenosine triphosphatase. Altered activity in essential hypertension. Hypertension (1986) 0.87
Activated protein C prevents glutamate- and thrombin-induced activation of nuclear factor-kappaB in cultured hippocampal neurons. Neuroscience (2009) 0.87
Age, race, blood pressure and renin: predictors for antihypertensive treatment with calcium antagonists. Am J Cardiol (1985) 0.87
Blockade of mitochondrial Ca2+ uptake by mitochondrial inhibitors amplifies the glutamate-induced calcium response in cultured cerebellar granule cells. FEBS Lett (1999) 0.87
Mus cervicolor murine leukemia virus isolate M813 belongs to a unique receptor interference group. J Virol (2001) 0.87
Calcium antagonists and the second drug for hypertensive therapy. Am J Med (1986) 0.86
Calcium transients in human platelets monitored by aequorin, fura-2 and quin-2: effects of protein kinase C activation and inhibition. Biochem Biophys Res Commun (1987) 0.86
Free calcium concentration in platelets closely relates to blood pressure in normal and essentially hypertensive subjects. Hypertension (1984) 0.86
LDL binds to surface-expressed human T-cadherin in transfected HEK293 cells and influences homophilic adhesive interactions. FEBS Lett (1999) 0.86
Urokinase plasminogen activator enhances neointima growth and reduces lumen size in injured carotid arteries. J Hypertens (2000) 0.86
Activation of phosphatidylinositol-specific phospholipase C in response to HDL3 and LDL is markedly reduced in cultured fibroblasts from Tangier patients. Arterioscler Thromb Vasc Biol (1995) 0.86
Human cardiac plasma concentrations of atrial natriuretic peptide quantified by radioreceptor assay. Biochem Biophys Res Commun (1985) 0.86
Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms. Mol Cell Biochem (1999) 0.86
Association between PRODH and schizophrenia is not confirmed. Mol Psychiatry (2003) 0.86
The 3rd international intercomparison on EPR tooth dosimetry: Part 1, general analysis. Appl Radiat Isot (2005) 0.86
High-density lipoprotein and low-density lipoprotein-mediated signal transduction in cultured human skin fibroblasts. Cell Signal (1995) 0.85
(-)-Adrenaline-induced, calcium-dependent phosphorylation of proteins in human platelets. J Clin Invest (1985) 0.84
Effect of tumour-promoting phorbol ester, thrombin and vasopressin on translocation of three distinct protein kinase C isoforms in human platelets and regulation by calcium. Biochem J (1992) 0.84
Rapid intracellular release of calcium in human platelets by stimulation of 5-HT2-receptors. Br J Pharmacol (1985) 0.84
Hemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine. Hypertension (1983) 0.83
Excitatory and inhibitory modulation of intracellular free calcium in human platelets by hormones and drugs. Eur J Pharmacol (1983) 0.83
Localization of the angiotensin II receptor subtypes in the human atrium. J Mol Cell Cardiol (1996) 0.82
Indications of proton-dominated cosmic-ray composition above 1.6 EeV. Phys Rev Lett (2010) 0.82
T-cadherin loss induces an invasive phenotype in human keratinocytes and squamous cell carcinoma (SCC) cells in vitro and is associated with malignant transformation of cutaneous SCC in vivo. Br J Dermatol (2010) 0.82
Femoral neck fatigue fracture. Arch Orthop Trauma Surg (1980) 0.82
Phosphoinositide and calcium signalling responses in smooth muscle cells: comparison between lipoproteins, Ang II, and PDGF. Biochem Biophys Res Commun (1992) 0.82
The Mus cervicolor MuLV isolate M813 is highly fusogenic and induces a T-cell lymphoma associated with large multinucleated cells. Virology (2001) 0.82
Translocation of protein kinase C is not required to inhibit the antigen-induced increase of cytosolic calcium in a mast cell line. Biochem Biophys Res Commun (1987) 0.82
Antihypertensive therapy with the long-acting calcium antagonist nitrendipine. J Cardiovasc Pharmacol (1984) 0.82
Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: six year results from a nationwide registry. Heart (2005) 0.81
Measurement of receptor induced changes in intracellular free calcium in human platelets. J Recept Res (1984) 0.81
Use of drugs with more than a twenty-four-hour duration of action. J Hypertens Suppl (1994) 0.81
Training astronauts using three-dimensional visualisations of the International Space Station. Acta Astronaut (1999) 0.81
Use of calcium antagonists as monotherapy in the management of hypertension. Am J Med (1984) 0.81
Ca(2+)-channel blockers modulate expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor genes stimulated by platelet-derived growth factor. Proc Natl Acad Sci U S A (1991) 0.81